Cite
HARVARD Citation
Mletzko, S. et al. (2017). Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study. Oncoimmunology. p. . [Online].